Furthermore, Ma et al. found that Tan IIA (anti-inflammatory drugs) reduced vascular endothelial inflammation and prevented plaque formation via the COX-2/TNF-a/NF-κB signaling pathway. The gene discussed is NFKB1; the disease is inflammation.